Desonide — Active Pharmaceutical Ingredient

Desonide is an active pharmaceutical ingredient found in 5 FDA-approved drug products. Forms: LOTION, SOLUTION/DROPS, OINTMENT, CREAM, GEL. Routes: TOPICAL, OTIC.

This content is for informational purposes only. Always consult a healthcare professional.

Desonide (5 brand names, 6 dosage forms, 2 routes)

Available dosage forms: LOTION, SOLUTION/DROPS, OINTMENT, CREAM, GEL, AEROSOL, FOAM.

Routes of administration: TOPICAL, OTIC.

Brand Names

  • DESONATE
  • DESONIDE
  • DESOWEN
  • TRIDESILON
  • VERDESO

Indications and Usage

Desonide Ointment, 0.05% is a low potency corticosteroid indicated for the relief of the inflammatory and pruritic manifestations of corticosteroid responsive dermatoses. It should not be used for longer than two weeks unless directed by a physician.

Dosage and Administration

Desonide Ointment, 0.05% should be applied to the affected area as a thin film from two to four times daily depending on the severity of the condition. As with other corticosteroids, therapy should be discontinued when control is achieved. If no improvement is seen within two weeks, reassessment of diagnosis may be necessary. Desonide Ointment, 0.05% should not be used with occlusive dressings.

Contraindications

Desonide Ointment, 0.05% is contraindicated in those patients with a history of hypersensitivity to any of the components of the preparation.

Adverse Reactions

In controlled clinical trials, the total incidence of adverse reactions associated with the use of Desonide Ointment, 0.05% was approximately 6%. These adverse reactions were erythema, induration, pruritus, irritation, oiliness, and peripheral edema. The following additional local adverse reactions have been reported infrequently with topical corticosteroids, and they may occur more frequently with the use of occlusive dressings and higher potency corticosteroids. These reactions are listed in approximate decreasing order of occurrence: dryness, folliculitis, acneiform eruptions, perioral dermatitis, allergic contact dermatitis, secondary infection, skin atrophy, striae, miliaria, burning and hypopigmentation. To report SUSPECTED ADVERSE REACTIONS, contact Encube Ethicals Private Limited at 1-833-285-4151 or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch.

Overdosage

Topically applied Desonide Ointment, 0.05% can be absorbed in sufficient amounts to produce systemic effects (see PRECAUTIONS).

⚠ Caution
Medical Disclaimer: This information is for educational purposes only. Always consult a healthcare professional before taking any medication.